Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-026654

Options or other derivatives

  • General Counsel and Secretary acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hadfield Robert General Counsel and Secretary 2018-04-25 Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…